Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Blueprint Medicines Corp (NASDAQ: BPMC) closed the day trading at $92.58 down -2.00% from the previous closing price of $94.47. In other words, the price has decreased by -$2.00 from its previous closing price. On the day, 1.21 million shares were traded. BPMC stock price reached its highest trading level at $94.91 during the session, while it also had its lowest trading level at $92.17.
Ratios:
For a better understanding of BPMC, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.27 and its Current Ratio is at 3.32. In the meantime, Its Debt-to-Equity ratio is 2.34 whereas as Long-Term Debt/Eq ratio is at 1.96.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JP Morgan on November 14, 2024, initiated with a Overweight rating and assigned the stock a target price of $126.
On October 24, 2024, UBS started tracking the stock assigning a Neutral rating and target price of $88.
On May 14, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $140.Stephens initiated its Overweight rating on May 14, 2024, with a $140 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 12 ’24 when ARIEL HURLEY bought 5,022 shares for $94.47 per share.
Haviland Kate sold 2,353 shares of BPMC for $227,304 on Nov 29 ’24. The CHIEF EXECUTIVE OFFICER now owns 150,824 shares after completing the transaction at $96.60 per share. On Nov 27 ’24, another insider, Rossi Christina, who serves as the CHIEF OPERATING OFFICER of the company, sold 2,274 shares for $95.10 each. As a result, the insider received 216,257 and left with 71,657 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BPMC now has a Market Capitalization of 6001285632 and an Enterprise Value of 5879752192. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.54 while its Price-to-Book (P/B) ratio in mrq is 18.76. Its current Enterprise Value per Revenue stands at 13.535 whereas that against EBITDA is -22.431.
Stock Price History:
Over the past 52 weeks, BPMC has reached a high of $121.90, while it has fallen to a 52-week low of $72.24. The 50-Day Moving Average of the stock is 0.86%, while the 200-Day Moving Average is calculated to be -4.23%.
Shares Statistics:
Over the past 3-months, BPMC traded about 627.08K shares per day on average, while over the past 10 days, BPMC traded about 504700 shares per day. A total of 63.45M shares are outstanding, with a floating share count of 61.55M. Insiders hold about 3.11% of the company’s shares, while institutions hold 102.37% stake in the company. Shares short for BPMC as of 1732838400 were 4185313 with a Short Ratio of 6.67, compared to 1730332800 on 4133244. Therefore, it implies a Short% of Shares Outstanding of 4185313 and a Short% of Float of 7.4200004.
